Variant report
Variant | nsv983319 |
---|---|
Chromosome Location | chr12:47734799-47738693 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:35)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:35 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr12:47737500-47737650 | AG04449 | skin: | n/a | n/a |
2 | CTCF | chr12:47737691-47737693 | HUVEC | blood vessel: | n/a | n/a |
3 | CTCF | chr12:47737520-47737670 | HA-sp | spinal cord: | n/a | n/a |
4 | CTCF | chr12:47737580-47737730 | HMEC | breast: | n/a | n/a |
5 | CTCF | chr12:47737604-47737672 | K562 | blood: | n/a | n/a |
6 | CTCF | chr12:47737596-47737689 | HUVEC | blood vessel: | n/a | n/a |
7 | CTCF | chr12:47737500-47737650 | GM12872 | blood: | n/a | n/a |
8 | CTCF | chr12:47737602-47737685 | Gliobla | brain: | n/a | n/a |
9 | CTCF | chr12:47737580-47737730 | HMF | breast: | n/a | n/a |
10 | CTCF | chr12:47737583-47737715 | Hela-S3 | cervix: | n/a | n/a |
11 | CTCF | chr12:47737580-47737730 | HCPEpiC | choroid plexus: | n/a | n/a |
12 | CTCF | chr12:47737599-47737668 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr12:47737560-47737710 | AoAF | blood vessel: | n/a | n/a |
14 | CTCF | chr12:47737500-47737650 | AoAF | blood vessel: | n/a | n/a |
15 | CTCF | chr12:47737520-47737670 | AG04450 | lung: | n/a | n/a |
16 | EP300 | chr12:47737752-47738165 | SK-N-SH_RA | brain: | n/a | n/a |
17 | EP300 | chr12:47737797-47738046 | SK-N-SH_RA | brain: | n/a | n/a |
18 | FOS | chr12:47737684-47738046 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr12:47737718-47738016 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr12:47738509-47738774 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | FOS | chr12:47738576-47738688 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOS | chr12:47738540-47738775 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr12:47737708-47738090 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr12:47737684-47738013 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | MYC | chr12:47737799-47738017 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | MYC | chr12:47737757-47737999 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | PBX3 | chr12:47737789-47738080 | SK-N-SH | brain: | n/a | n/a |
28 | POLR2A | chr12:47736146-47736240 | K562 | blood: | n/a | n/a |
29 | POLR2A | chr12:47737705-47738058 | U87 | brain: | n/a | n/a |
30 | POLR2A | chr12:47737553-47737610 | HUVEC | blood vessel: | n/a | n/a |
31 | POLR2A | chr12:47737734-47738058 | U87 | brain: | n/a | n/a |
32 | STAT3 | chr12:47738641-47738707 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | STAT3 | chr12:47738560-47738811 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | STAT3 | chr12:47738576-47738690 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | STAT3 | chr12:47737994-47737998 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000258116 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554859986 | chr12:47734851-47734852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs28401511 | chr12:47734879-47734880 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs540396011 | chr12:47734882-47734883 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184093200 | chr12:47734902-47734903 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs215350 | chr12:47734911-47734912 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs545965983 | chr12:47734915-47734916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115380887 | chr12:47734976-47734977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377576783 | chr12:47734997-47734998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185051224 | chr12:47735000-47735001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562002398 | chr12:47735027-47735028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs202171067 | chr12:47735035-47735036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527892679 | chr12:47735057-47735058 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189562823 | chr12:47735082-47735083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114854228 | chr12:47735088-47735089 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538769430 | chr12:47735122-47735123 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12302802 | chr12:47735151-47735152 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs568840550 | chr12:47735154-47735155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375671312 | chr12:47735201-47735202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34902693 | chr12:47735251-47735252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182217682 | chr12:47735253-47735254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76622227 | chr12:47735303-47735304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10492012 | chr12:47735312-47735313 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553967167 | chr12:47735340-47735341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186905535 | chr12:47735348-47735349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372993557 | chr12:47735364-47735365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556433744 | chr12:47735396-47735397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs215351 | chr12:47735400-47735401 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs546324215 | chr12:47735404-47735405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78953588 | chr12:47735407-47735408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560016743 | chr12:47735413-47735414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576034635 | chr12:47735435-47735436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113847212 | chr12:47735437-47735438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2040644 | chr12:47735480-47735481 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs528004003 | chr12:47735485-47735486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1730454 | chr12:47735500-47735501 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs375120756 | chr12:47735560-47735561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145123509 | chr12:47735598-47735599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533320252 | chr12:47735673-47735674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2040645 | chr12:47735677-47735678 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs2040646 | chr12:47735701-47735702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs78610354 | chr12:47735702-47735703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75965261 | chr12:47735723-47735724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568046132 | chr12:47735734-47735735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2040647 | chr12:47735757-47735758 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs147179244 | chr12:47735786-47735787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192737285 | chr12:47735835-47735836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140407971 | chr12:47735871-47735872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117258321 | chr12:47735875-47735876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144161530 | chr12:47735925-47735926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11183877 | chr12:47735975-47735976 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Breast cancer | 21804112 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:47723200-47742200 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr12:47732400-47735600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr12:47734200-47735000 | Enhancers | Fetal Lung | lung |
4 | chr12:47734600-47737400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr12:47737400-47738400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr12:47737400-47738800 | Enhancers | Osteobl | bone |
7 | chr12:47737400-47748400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr12:47737600-47737800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr12:47737600-47738200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr12:47737600-47738200 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr12:47737600-47741600 | Enhancers | Liver | Liver |
12 | chr12:47737800-47738200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
13 | chr12:47738000-47738200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr12:47738000-47738200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr12:47738200-47740200 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |